by healthadvances Posted on July 11, 2022July 12, 2022 Demystifying SARS-CoV-2 Testing for COVID-19 (Fourth Edition – The Long-Term Dx Industry Impact) Read More
by healthadvances Posted on July 6, 2022July 21, 2022 Xenotransplantation: Market Disrupter or Expander? Read More
by healthadvances Posted on June 24, 2022June 24, 2022 From Treating Cancer to Curing Cancer – The Promise of mRNA Vaccines in Oncology Read More
by healthadvances Posted on June 16, 2022June 16, 2022 ASCO 2022: Striving to Ensure No Patient is Left Behind Read More
by healthadvances Posted on May 4, 2022 Digital Health in Japan and Korea – Where Is It Heading? Read More
by healthadvances Posted on May 2, 2022 Opportunities and Challenges for Drug Makers in MDD Read More
by healthadvances Posted on February 25, 2022 Strategies to Overcome Challenges in Commercializing Treatments for Rare Diseases Read More
by healthadvances Posted on February 15, 2022 Women’s Health at Home: Reflections on a Rapidly Growing Space Read More
by healthadvances Posted on October 8, 2021 Building and Defending Markets; Reflections on Attending DTx and NASS Conferences Read More
by healthadvances Posted on October 1, 2021October 1, 2021 Resurgence in Drug Development for Renal Diseases Read More
by healthadvances Posted on September 29, 2021October 1, 2021 AI in Healthcare: Insights from Two Decades of FDA Approvals Read More
by healthadvances Posted on August 6, 2021August 9, 2021 Evidence Generation Strategy under Germany’s Digital Healthcare: Is More Better? Read More
by healthadvances Posted on July 21, 2021 India, the Generic Manufacturing Powerhouse, Biosimilar Next? Read More
by healthadvances Posted on June 30, 2021 Tencent-Backed Wedoctor Is Going Public: What Are the Next Steps for Chinese Digital Health Companies? Read More
by healthadvances Posted on January 15, 2021 Google Has Officially Acquired Fitbit. Now What? Read More
by healthadvances Posted on September 24, 2020October 22, 2020 When Off-Label is Your Biggest Competition: Rituximab in Autoimmune Diseases Read More
by healthadvances Posted on September 18, 2020 How COVID-19 Testing Demand Threw off Thermo Fisher’s Acquisition of Qiagen Read More
by healthadvances Posted on September 15, 2020 Hong Kong Exchange: Nurturing China’s Biotech Valley Read More
